Advisor Group Holdings, Inc. Cue Biopharma, Inc. Transaction History
Advisor Group Holdings, Inc.
- $52.6 Billion
- Q2 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 680 shares of CUE stock, worth $516. This represents 0.0% of its overall portfolio holdings.
Number of Shares
680
Previous 680
-0.0%
Holding current value
$516
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CUE
# of Institutions
49Shares Held
17.6MCall Options Held
0Put Options Held
0-
Bleichroeder LP New York, NY6.82MShares$5.18 Million1.47% of portfolio
-
Catalytic Wealth Ria, LLC Cambridge, MA3.33MShares$2.53 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.19MShares$2.42 Million0.0% of portfolio
-
Black Rock Inc. New York, NY757KShares$575,1190.0% of portfolio
-
Geode Capital Management, LLC Boston, MA692KShares$526,0510.0% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $26.9M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...